Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients

British Journal of Cancer

Volumn 74, Issue 7, 1996, Pages 1081-1084

  Mora, J ^a   Gascon N ^a   Tabernero, J Ma ^a   Rodriguez Espinosa J ^a   Gonzalez Sastre F ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Bladder carcinoma; Human chorionic gonadotropin; Tumour marker

Indexed keywords

ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECTOPIC HORMONE PRODUCTION; FEMALE; GONADOTROPIN BLOOD LEVEL; GONADOTROPIN RELEASE; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029744423     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.493     Document Type: Article

References (20)

1. ALFTHAN H, HAGLUND G, ROBERTS P AND STENMAN UH. (1992). Elevation of free β subunit of human choriogonadotropin and core β fragment of human choriogonadotropin in serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res., 52, 4628-4633.
2. COLE LA AND KARDANA A. (1992). Discordant results in human chorionic gonadotropin assays. Clin. Chem., 38, 263-270
3. COLE LA, SEIFER DB, KARDANAA AND BRAUNSTEIN GD. (1993). Selecting human chorionic gonadotropin immunoassays: consideration of cross-reacting molecules in first-trimester pregnancy serum and urine. Am. J. Obstet. Gynecol., 168, 1580-1586.
4. COLE LA, KOHORN EI AND KIM GS. (1994). Detecting and monitoring trophoblastic disease: new perspective in measuring human chorionic gonadolropin levels. J. Reprod. Med., 39, 193-200.
5. DEXEUS F, LOGOTHETIS C, HOSSAN E AND SAMUELS ML. (1986). Carcinoembryonic antigen and betaHCG as serum markers for advanced urothelial malignancies. J. Urol., 136, 403-407.
6. FAN C, GOTO S, FURUHASHI Y AND TOMODA Y. (1987). Radioimmunoassay of the serum free β-subunit of human chorionic gonadotropin in trophoblastic disease. J. Clin. Endocrinol. Methods, 64, 313-318.
7. FOSSA SD, BERNER AA, JACOBSEN AB, WAEHRE H, KVARSTEIN B, URNEST OGREID P, BJERKLUND TE, SILDE J, NESLAND JM AND PETTERSEN EO. (1993). Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer. Br. J. Cancer, 68, 572 578.
8. HATTORI M, YOSHIMOTO Y, MATSUKURA S AND FUJITA T. (1980). Qualitative and quantitative analyses of human chorionic gonadotropin and its subunits produced by malignant tumours. Cancer, 46, 355-361.
9. HOERMANN R, GERBES AL, SPOETTL G, JÜNGST D AND MANN K. (1992). Immunoreactive human chorionic gonadotropin and its free β subunit in serum and ascites of patients with malignant tumors. Cancer Res., 52, 1520-1524.
10. HOERMANN R, BERGER P, SPOETTL G, GILLESBERGER F, KARDANA A, COLE LA AND MANN K. (1994). Immunological recognition and clinical significance of nicked human chorionic gonadotropin in testicular cancer. Clin. Chem., 40, 2306-2312.
11. ILES RK AND CHARD T. (1991). Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential. J. Urol., 145, 453-458.
12. ILES RK, JENKINS BJ, OLIVER RT, BLANDY JP AND CHARD T. (1989). Beta human chorionic gonadotropin in serum and urine. A marker for metastatic urothelial cancer. Br. J. Urol., 64, 241-244.
13. MCLOUGHLIN J, PEPERA T, BRIDGER J. WILLIAMS, G. (1991). Serum and urinary levels of beta HCG in patients with transitional cell carcinomas. (1991). Br. J. Cancer, 63, 822-824.
14. MADERSBACHER S, KLIEBER R, MANN K, MARTH C, TABARELLI M, WICK G AND BERGER P. (1992). Free α-subunit, free β-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients, Clin. Chem., 38, 370-376.
15. MARCILLAC I, TROALEN F, BIDART JM, GUILLANI P, RIBRAY V AND ESCUDIER B. (1992). Free human chorionic gonadotropin β subunit in gonadal and nongonadal neoplasms. Cancer Res., 52, 3901-3907.
16. OLIVER RT, STEPHENSON C, COLLINO CE AND PARKINSON MC. (1988). Clinicopathological significance of immunoreactive beta-hCG production by bladder cancer. Mol. Biother., 1, 43-45.
17. PASSING H AND BABLOK W. (1983). A new biometrical procedure for testing the equality of measurements for two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry. Part I. J. Clin. Chem. Clin. Biochem., 21, 709-720.
18. RINKER AD AND TIETZ NW. (1989). β-hCG vs intact hCG assays in the detection of trophoblastic disease. Clin. Chem., 35, 1799-1800.
19. SALLER B, CLARA R, SPOETTL G, SIDDLE K AND MANN K. (1990). Testicular cancer secretes intact human choriogonadotropin (hCG) and its free β-subunit: evidence that hCG (-hCG β) assays are the most reliable in diagnosis and follow-up. Clin. Chem., 36, 234-239.
20. SMITH DJ, EVANS HJ, NEWMAN J AND CHAPPLE CR. (1994). Ectopic human chorionic gonadotrophin (HCG) production: is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder? Br. J. Urol., 73, 409-412.